BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
企業コードBHST
会社名Bioharvest Sciences Inc
上場日Aug 05, 2015
最高経営責任者「CEO」Sobel (Ilan)
従業員数- -
証券種類Ordinary Share
決算期末Aug 05
本社所在地1140 - 625 Howe Street
都市VANCOUVER
証券取引所NASDAQ OMX - NASDAQ BASIC
国Canada
郵便番号V6C 2T6
電話番号16046221186
ウェブサイトhttps://bioharvest.com/about/
企業コードBHST
上場日Aug 05, 2015
最高経営責任者「CEO」Sobel (Ilan)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし